+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Quantum Genomics SA (ALQGC) - Financial and Strategic SWOT Analysis Review

  • ID: 4278715
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Quantum Genomics SA (Quantum Genomics) is a biopharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (BAPAI), a real triple action innovative therapeutic platform. Quantum Genomics BAPAI products pipeline include QGC001 for the treatment of high blood pressure with monotherapy drug; QGC011 for the treatment of hypertension through combination therapy; QGC006 for the optimization of the treatment of hypertension with a monotherapy drug; and QGC101 for the prevention and treatment of heart failure. The company partners with biotech research entities, academic teams, and pharmaceutical and bio-science companies to develop new drugs. QGS is headquartered in Paris, France.

Quantum Genomics SA Key Recent Developments

Feb 05, 2018: Quantum Genomics strengthens its Scientific Advisory Board with the appointment of Professor Frans Leenen, a renowned expert in congestive heart failure
Oct 03, 2017: Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update
Jul 11, 2017: Quantum Genomics begins trading in the U.S. on OTCQX
Jun 30, 2017: Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board
May 23, 2017: Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States

This comprehensive SWOT profile of Quantum Genomics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Quantum Genomics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Quantum Genomics SA - Key Information
  • Quantum Genomics SA - Overview
  • Quantum Genomics SA - Key Employees
  • Quantum Genomics SA - Key Employee Biographies
  • Quantum Genomics SA - Key Operational Heads
  • Quantum Genomics SA - Major Products and Services
  • Quantum Genomics SA - History
  • Quantum Genomics SA - Company Statement
  • Quantum Genomics SA - Locations And Subsidiaries
  • Quantum Genomics SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Quantum Genomics SA - Business Description
  • Quantum Genomics SA - Corporate Strategy
  • Quantum Genomics SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Quantum Genomics SA - Strengths
  • Quantum Genomics SA - Weaknesses
  • Quantum Genomics SA - Opportunities
  • Quantum Genomics SA - Threats
  • Quantum Genomics SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Quantum Genomics SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Quantum Genomics SA, Key Information
  • Quantum Genomics SA, Key Ratios
  • Quantum Genomics SA, Share Data
  • Quantum Genomics SA, Major Products and Services
  • Quantum Genomics SA, History
  • Quantum Genomics SA, Key Employees
  • Quantum Genomics SA, Key Employee Biographies
  • Quantum Genomics SA, Key Operational Heads
  • Quantum Genomics SA, Other Locations
  • Quantum Genomics SA, Subsidiaries
  • Quantum Genomics SA, Key Manufacturing facilities
  • Quantum Genomics SA, Key Competitors
  • Quantum Genomics SA, SWOT Analysis
  • Quantum Genomics SA, Ratios based on current share price
  • Quantum Genomics SA, Annual Ratios
  • Quantum Genomics SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Quantum Genomics SA, Performance Chart
  • Quantum Genomics SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3